Multicenter phase II study of infusional 5-fluorouracil (5-FU), leucovorin, and oxaliplatin, plus biweekly cetuximab as first-line treatment in patients with metastatic colorectal cancer (CELINE trial)

The current phase II study investigated the efficacy and safety of biweekly cetuximab combined with standard oxaliplatin-based chemotherapy [infusional 5-fluorouracil (5-FU), leucovorin, and oxaliplatin (FOLFOX-6)] in the first-line treatment of KRAS wild-type metastatic colorectal cancer (mCRC). Si...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncol Lett
Main Authors: Kotake, Masanori, Aoyama, Toru, Munemoto, Yoshinori, Doden, Kenji, Kataoka, Masato, Kobayashi, Kenji, Nishimura, Genichi, Fujita, Hidehito, Nakamura, Keishi, Takehara, Akira, Tanaka, Chihiro, Sakamoto, Junichi, Nagata, Naoki, Oba, Koji, Kondo, Ken
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2017
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5351391/
https://ncbi.nlm.nih.gov/pubmed/28356954
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2016.5505
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados